Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLS | AZN | AMGN | GILD | BMY |
| Company | Apellis Pharmaceuticals Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 40.95 | 181.48 | 321.91 | 132.84 | 57.00 |
| High | 40.97 | 181.98 | 327.37 | 133.80 | 57.48 |
| Low | 40.93 | 180.00 | 320.52 | 131.89 | 56.73 |
| Latest | 40.97 | 181.36 | 327.01 | 133.80 | 57.11 |
| Change | unch | -2.10 | +3.16 | +1.11 | -0.27 |
| % Change | -0.01% | -1.14% | +0.98% | +0.84% | -0.47% |
| Volume | 2,345,469 | 1,954,294 | 1,950,913 | 2,992,117 | 6,985,781 |
| 20-Day Average Volume | 3,836,535 | 1,989,394 | 2,552,080 | 5,297,563 | 9,797,628 |
| Previous Close | 40.97 | 183.46 | 323.85 | 132.69 | 57.38 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 40.89 | 194.81 | 344.44 | 134.92 | 58.62 |
| 20-Day Raw Stochastic | 90.28% | 5.92% | 16.16% | 36.43% | 6.99% |
| 20-Day Relative Strength | 82.66 | 36.92 | 37.90 | 44.31 | 44.92 |
| Weighted Alpha | +26.21 | +26.24 | +16.38 | +29.83 | +22.88 |
| Today's Opinion | 100% Buy | 8% Buy | 8% Sell | 8% Buy | 24% Buy |
| Previous Opinion | 100% Buy | 24% Buy | 24% Sell | 8% Buy | 24% Buy |
| Last Month's Opinion | 24% Buy | 88% Buy | 24% Buy | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.06% since 04/28/26 | -2.71% since 04/28/26 | -3.76% since 04/28/26 | +3.07% since 04/28/26 | -2.14% since 04/28/26 |
| Low | 40.93 on 05/05/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.96 on 04/30/26 | 56.73 on 05/05/26 |
| High | 40.99 on 04/29/26 | 190.00 on 04/30/26 | 349.54 on 04/30/26 | 133.65 on 05/05/26 | 60.78 on 04/30/26 |
| 1-Month | |||||
| %Chg | +1.37% since 04/02/26 | -10.75% since 04/02/26 | -6.07% since 04/02/26 | -4.64% since 04/02/26 | -4.34% since 04/02/26 |
| Low | 40.41 on 04/06/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 56.73 on 05/05/26 |
| High | 41.00 on 04/28/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +81.58% since 02/05/26 | -2.96% since 02/05/26 | -11.14% since 02/05/26 | -10.81% since 02/05/26 | -4.21% since 02/05/26 |
| Low | 16.83 on 03/30/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 56.45 on 03/24/26 |
| High | 41.00 on 04/28/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +105.34% since 11/05/25 | +11.90% since 11/05/25 | +2.17% since 11/05/25 | +8.68% since 11/05/25 | +22.69% since 11/05/25 |
| Low | 16.83 on 03/30/26 | 166.74 on 11/06/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 41.00 on 04/28/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,245,021 | 284,529,568 | 174,776,976 | 164,697,760 | 117,154,760 |
| Shares Outstanding, K | 128,021 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 1,003,780,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | 22,390,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 199,910,000 | 15,288,000,000 | 8,618,000,000 | 7,925,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -58,950,000 | 3,080,000,000 | 1,819,000,000 | 2,183,000,000 | 2,677,000,000 |
| 60-Month Beta | -0.24 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.47 on 02/24/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 1.86 on 02/10/26 | 1.58 on 04/30/26 |
| Earnings Date | 05/06/26 | 08/04/26 | 08/04/26 | 05/07/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 315.08 | 19.95 | 14.92 | 16.15 | 9.82 |